These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32614772)

  • 41. The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study.
    Jang YJ; Choy YS; Nam CM; Moon KT; Park EC
    BMC Nephrol; 2018 Jun; 19(1):127. PubMed ID: 29871604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.
    Brancati FL; Whelton PK; Randall BL; Neaton JD; Stamler J; Klag MJ
    JAMA; 1997 Dec; 278(23):2069-74. PubMed ID: 9403420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria.
    Nelson RG; Knowler WC; McCance DR; Sievers ML; Pettitt DJ; Charles MA; Hanson RL; Liu QZ; Bennett PH
    Diabetologia; 1993 Oct; 36(10):1087-93. PubMed ID: 8243859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 46. Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: hospital admission rate for renal complications, and incidence of end-stage renal disease and renal death.
    Joshy G; Dunn P; Fisher M; Lawrenson R
    Diabetologia; 2009 Aug; 52(8):1474-8. PubMed ID: 19436991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    BMC Nephrol; 2017 Aug; 18(1):257. PubMed ID: 28764641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
    Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
    Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Weight change and microvascular outcomes in patients with new-onset diabetes: a nationwide cohort study.
    Koh ES; Han KD; Kim MK; Kim ES; Lee MK; Nam GE; Kwon HS
    Korean J Intern Med; 2021 Jul; 36(4):932-941. PubMed ID: 32872746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early referral to a nephrologist is associated with better outcomes in type 2 diabetes patients with end-stage renal disease.
    Frimat L; Loos-Ayav C; Panescu V; Cordebar N; Briançon S; Kessler M
    Diabetes Metab; 2004 Feb; 30(1):67-74. PubMed ID: 15029100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age at onset of childhood-onset type 1 diabetes and the development of end-stage renal disease: a nationwide population-based study.
    Svensson M; Nyström L; Schön S; Dahlquist G
    Diabetes Care; 2006 Mar; 29(3):538-42. PubMed ID: 16505502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetic kidney disease and vascular comorbidities in patients with type 2 diabetes mellitus in a developing country.
    Bentata Y; Chemlal A; Karimi I; El Alaoui F; Haddiya I; Abouqal R
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):1035-43. PubMed ID: 26354588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.
    Foster MC; Inker LA; Hsu CY; Eckfeldt JH; Levey AS; Pavkov ME; Myers BD; Bennett PH; Kimmel PL; Vasan RS; Coresh J; Nelson RG;
    Am J Kidney Dis; 2015 Jul; 66(1):75-83. PubMed ID: 25773485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.
    Keane WF; Brenner BM; de Zeeuw D; Grunfeld JP; McGill J; Mitch WE; Ribeiro AB; Shahinfar S; Simpson RL; Snapinn SM; Toto R;
    Kidney Int; 2003 Apr; 63(4):1499-507. PubMed ID: 12631367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk for ESRD in type 1 diabetes remains high despite renoprotection.
    Rosolowsky ET; Skupien J; Smiles AM; Niewczas M; Roshan B; Stanton R; Eckfeldt JH; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2011 Mar; 22(3):545-53. PubMed ID: 21355053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
    Ma RC; Tam CH; Wang Y; Luk AO; Hu C; Yang X; Lam V; Chan AW; Ho JS; Chow CC; Tong PC; Jia W; Ng MC; So WY; Chan JC
    JAMA; 2010 Aug; 304(8):881-9. PubMed ID: 20736472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.